Investment Summary |
|
|---|---|
| Date | 2024-01-31 |
| Target | Mark Styler |
| Sector | Apparel/Textiles |
| Sellers(s) | Trustar Capital |
| Deal Type | Sold to Management |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1978 |
| PE ASSETS | 8.7B USD |
| Size | Mega |
| Type | Sector Agnostic |
Trustar Capital is the private equity arm of financial services/asset manager CITIC Group. Trustar Capital separates its private equity investment activity into three groups; China, Japan, and the US. In general, Trustar looks to invest in companies with 'strong franchises', with established brands and high barriers to entry. For US-based opportunities, the firm looks to leverage its connections in China. Broad areas of interest include niche manufacturing, consumer products, and business services. The Firm does not invest in start-ups or distressed businesses. Trustar Capital is based in Hong Kong.
| DEAL STATS | # |
|---|---|
| Overall | 28 of 28 |
| Sector: Apparel/Textiles M&A | 1 of 1 |
| Type: Sold to Management M&A Deals | 3 of 3 |
| Country: Japan M&A | 8 of 8 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-08-29 |
Moritex
Saitama, Japan Moritex manufactures businesses related to applied optical equipment and functional materials. Moritex was founded in 1973 and is based in Saitama, Japan. |
Sell | $275M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-02 |
Guilong Pharmaceutical
Maanshan, China Guilong Pharmaceutical is a pharmaceutical company that manufactures and distributes a variety of drugs, with a focus on throat, cardiocerebral vascular, and digestive system medications. Guilong Pharmaceutical was founded in 1989 and is based in Maanshan, China. |
Buy | - |
